Cargando…
A Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor
Patient: Female, 76-year-old Final Diagnosis: Neuroendocrine carcinoma Symptoms: Anxiety • bone pain • diarrhea • fatigue • palpitations • weight loss Medication: — Clinical Procedure: Parathyroidectomy Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Neuroendocrine neoplasms are commonly see...
Autores principales: | Quinn, Catherine Dianne, Chaudhary, Fihr, Gould-Simon, Aron, Chen, Baorong, Bhandal, Harsimran Singh, Chaudhary, Uzair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305989/ https://www.ncbi.nlm.nih.gov/pubmed/35849548 http://dx.doi.org/10.12659/AJCR.935783 |
Ejemplares similares
-
Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
por: Medas, Fabio, et al.
Publicado: (2019) -
Malignant Hypercalcemia Induced by the Ectopic Production of Intact Parathyroid Hormone (PTH)
por: Neves, Ana, et al.
Publicado: (2023) -
OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020) -
Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
por: De Rose, Domenico Umberto, et al.
Publicado: (2019) -
Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?
por: Hocher, Berthold, et al.
Publicado: (2012)